Jaraba-Álvarez Wendy V, Uscanga-Palomeque Ashanti C, Sanchez-Giraldo Vanesa, Madrid Claudia, Ortega-Arellano Hector, Halpert Karolynn, Quintero-Gil Carolina
BioXscience, BioXcellerator, Medellín, Colombia.
BioXtech, Medellín, Colombia.
Front Cell Dev Biol. 2025 Jun 9;13:1609082. doi: 10.3389/fcell.2025.1609082. eCollection 2025.
Mesenchymal stem cells (MSCs) are a cornerstone of regenerative medicine, primarily due to their ability to secrete bioactive factors that modulate inflammation, promote tissue repair, and support regeneration. Recent research highlights the importance of preserving the native cellular microenvironment to optimize MSC function and survival post-transplantation. Preconditioning strategies, such as hypoxia exposure, have emerged as powerful tools to enhance MSC therapeutic potential by mimicking physiological conditions in their natural niche. This perspective article explores the metabolic adaptations induced by hypoxia in MSCs, focusing on shifts in mitochondrial function, glycolysis, oxidative phosphorylation, and metabolic intermediates that enhance cellular survival and bioactivity. We also discuss how these metabolic changes influence the composition and function of MSC-derived secreted factors, particularly exosomes and other extracellular vesicles, in modulating tissue repair. Furthermore, we provide an overview of preclinical and clinical studies that have evaluated hypoxia-preconditioned MSCs and their byproducts, assessing their efficacy in various therapeutic contexts. Special attention is given to the role of hypoxia-induced mitochondrial adaptations in improving MSC function and the emerging potential of metabolic inhibitors or respiration modulators as strategies to further refine MSC-based therapies. By integrating metabolic insights with clinical evidence, we aim to offer a comprehensive perspective on optimizing MSC culture conditions to enhance their regenerative properties, acknowledging that this remains a theoretical standpoint, as conventional culture methods are generally not conducted under hypoxic conditions. This approach holds promise for the development of more effective therapeutic strategies that leverage metabolic modulation to improve MSC-based interventions for a range of diseases.
间充质干细胞(MSCs)是再生医学的基石,主要是因为它们能够分泌生物活性因子,调节炎症、促进组织修复并支持再生。最近的研究强调了保留天然细胞微环境以优化MSC移植后功能和存活的重要性。预处理策略,如缺氧暴露,已成为通过模拟其天然生态位中的生理条件来增强MSC治疗潜力的有力工具。这篇观点文章探讨了缺氧在MSCs中诱导的代谢适应性,重点关注线粒体功能、糖酵解、氧化磷酸化以及增强细胞存活和生物活性的代谢中间体的变化。我们还讨论了这些代谢变化如何影响MSC衍生的分泌因子,特别是外泌体和其他细胞外囊泡在调节组织修复中的组成和功能。此外,我们概述了评估缺氧预处理的MSCs及其副产物的临床前和临床研究,评估了它们在各种治疗环境中的疗效。特别关注缺氧诱导的线粒体适应性在改善MSC功能中的作用,以及代谢抑制剂或呼吸调节剂作为进一步优化基于MSC的治疗策略的新兴潜力。通过将代谢见解与临床证据相结合,我们旨在提供一个关于优化MSC培养条件以增强其再生特性的全面观点,同时承认这仍然是一个理论观点,因为传统培养方法通常不在缺氧条件下进行。这种方法有望开发出更有效的治疗策略,利用代谢调节来改善针对一系列疾病的基于MSC的干预措施。